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Gene deliveryHere we present a quantitative mechanism-based investigation aimed at comparing the cell uptake, intracellular
trafﬁcking, endosomal escape and ﬁnal fate of lipoplexes and lipid–protamine/deoxyribonucleic acid (DNA)
(LPD) nanoparticles (NPs) in living Chinese hamster ovary (CHO) cells. As a model, two lipid formulations were
used for comparison. The ﬁrst formulation is made of the cationic lipid 1,2-dioleoyl-3-trimethylammonium-
propane (DOTAP) and the zwitterionic lipid dioleoylphosphocholine (DOPC), while the second mixture is made
of the cationic 3β-[N-(N,N-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) and the zwitterionic helper
lipid dioleoylphosphatidylethanolamine (DOPE). Our ﬁndings indicate that lipoplexes are efﬁciently taken up
through ﬂuid-phase macropinocytosis, while a less efﬁcient uptake of LPD NPs occurs through a combination of
bothmacropinocytosis and clathrin-dependent pathways. Inside the cell, both lipoplexes and LPD NPs are actively
transported towards the cell nucleus, as quantitatively addressed by spatio-temporal image correlation spectros-
copy (STICS). For each lipid formulation, LPD NPs escape from endosomes more efﬁciently than lipoplexes.
When cells were treated with DOTAP–DOPC-containing systems the majority of the DNA was trapped in the
lysosome compartment, suggesting that extensive lysosomal degradation was the rate-limiting factors in
DOTAP–DOPC-mediated transfection. On the other side, escape from endosomes is large for DC-Chol–DOPE-
containing systems most likely due to DOPE and cholesterol-like molecules, which are able to destabilize the
endosomal membrane. The lipid-dependent and structure-dependent enhancement of transfection activity
suggests that DNA is delivered to the nucleus synergistically: the process requires both the membrane-fusogenic
activity of the nanocarrier envelope and the employment of lipid species with intrinsic endosomal rupture ability.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Lipid nanocarriers have attracted much attention because of being
biodegradable, nontoxic and nonimmunogenic delivery vectors for
drugs and genes [1–3]. Among all the common lipid systems, lipoplexes
and core–shell-type lipid nanoparticles (CSLNPs) have emerged as the
two main classes of nanocarriers [4]. Lipoplexes are typically formed by
bulk mixing between cationic liposomes and DNA solutions and are
arranged as multilayer structures in which DNA is intercalated between
alternating lipid bilayers [8–12] (Fig. 1). Historically, lipoplexes
have been used for decades [5–7], but limitations concerning their
physical and chemical stability, batch-to-batch reproducibility and lowcciolo).
ights reserved.transfection efﬁciency (TE) have been thoroughly described [8–12]. Con-
versely, CSLNPs were originally synthesized with a lipid shell and a core
composed of inorganic materials such as silica [13], or organic materials
such as polymermicrogels [14]. Based on the concept of core–shell archi-
tecture, lipid NPs composed of two functional building blocks were
synthesized [15,16]. The ﬁrst building block is a core of DNA complexed
with protamine or other polycations (Fig. 1). The core of lipid/protamine–
DNA (LPD) NPs acts as the carrier for the gene payload, provides me-
chanical stability, controlled morphology, narrow size distribution and
reduces the amount of lipid needed for complete drug encapsulation.
The second building block is the lipid shell that protects DNA from deg-
radation, imparts biocompatibility and improves stability in biological
ﬂuids. Optimization of the core and the shell of LPD NPs can result in
tunable and sustained drug release proﬁles. A recent suggestion is that
LPD NPs can exhibit superior performances in the transfection potency
Fig. 1. (Cartoon) Mechanism of formation of lipoplexes and lipid nanoparticles: lipoplexes are typically formed by bulk mixing between cationic liposomes and DNA solutions and are
arranged as multilayer structures in which DNA is intercalated between alternating lipid bilayers. Lipid NPs are composed of a core of DNA complexed with protamine and covered by
a lipid shell that protects DNA from degradation, imparts biocompatibility and improves stability in biological ﬂuids. The hydrodynamic radius, D, and the zeta-potential of DOTAP–
DOPC/DNA (panel A), DC-Chol–DOPE/DNA (panel B) lipoplexes and DOTAP–DOPC/P-DNA (panel C), DC-Chol–DOPE/P-DNA (panel D) nanoparticles, as a function of the cationic lipid/
DNA charge ratio, ρ.
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lipid composition and lipid/DNA charge ratio) [17], but the precise reason
remains unclear. It is generally accepted that TE is rate limited by intra-
cellular processes such as cellular uptake, intracellular trafﬁcking and
endosomal escape [18–24]. Therefore, a systematic, quantitative and
mechanism-based investigation (and comparison) of the transfection
process of lipoplexes and LPD NPs in live cells is needed if we want to
substantially improve the effectiveness of lipid vectors. The acquired in-
formationwould also enable us to recognize towhat extent andhowspe-
ciﬁc intracellular barriers affect the vector transfection activity. Thus,
here we propose a quantitative mechanism-based investigation of the
cell uptake, intracellular trafﬁcking, endosomal escape and ﬁnal fate of
lipoplexes and LPD NPs in Chinese hamster ovary (CHO) living cells. Inthe present study, two lipid formulations were used for comparison
since they are diversely potent andwidely used [25–27]. The ﬁrst formu-
lation is made of the cationic lipid 1,2-dioleoyl-3-trimethylammonium-
propane (DOTAP) and the zwitterionic lipid dioleoylphosphocholine
(DOPC). The second mixture is made of the cationic 3β-[N-(N,N-
dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) and the
zwitterionic helper lipid dioleoylphosphatidylethanolamine (DOPE).
Our ﬁndings indicate that ﬂuid-phase macropinocytosis is the main in-
ternalization pathway of lipoplexes, while the uptake of LPD NPs occurs
equally through macropinocytosis and the classical clathrin-associated
endocytosis. Inside the cell, both lipoplexes and LPD NPs are actively
transported towards the cell nucleus. For each lipid formulation, LPD
NPs escaped from endosomes more efﬁciently than lipoplexes, most
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fraction of DOTAP–DOPC-containing systems reaches the lysosome
compartment, suggesting that poor endosomal escape and extensive
lysosomal degradation are the most relevant barriers in DOTAP–
DOPC-mediated transfection. On the other side, escape from endosome
is large in DC-Chol–DOPE-containing systemsmost likely due to the use
of DOPE and cholesterol-like molecules, which can cause rupture of
endosomes. Collectively, our mechanism-based investigation shows
that efﬁcient gene delivery requires both the membrane-fusogenic
activity of the core–shell-type nanostructure and the use of lipid species
with a tendency to destabilize endosomal membrane.
2. Materials and methods
2.1. Cationic liposomes
Cationic 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and
(3β-[N-(N′,N′-dimethylaminoethane)-carbamoyl])-cholesterol (DC-
Chol), the neutral helper lipids dioleoylphosphatidylethanolamine
(DOPE) and dioleoylphosphocholine (DOPC), and the ﬂuorescent neu-
tral lipids 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]
dodecanoyl]-sn-glycero-3-phosphocholine (PC-NBD) and 1-oleoyl-2-
{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-
3-phosphoethanolamine (PE-NBD) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA) and used without further puriﬁcation.
Cationic liposomes (CLs) were prepared according to standard pro-
tocols. In brief, the proper amount of lipids was dissolved in chloroform
and the solvent was evaporated under vacuum for at least 24 h. The
obtained lipid ﬁlms were hydrated with the appropriate amount of
Tris–HCl buffer solution (10−2 M, pH 7.4) to achieve the desired ﬁnal
concentration (1 mg/ml). Liposome dispersions were sonicated to
clarity to prepare small unilamellar vesicles (SUVs). Experiments
aimed at clarifying the mechanism of endosomal escape were per-
formed by using CLs prepared with PC-NBD and PE-NBD mixed with
unlabeled DOPC and DOPE to obtain labeled liposomes.
2.2. Lipoplexes
When adequate amounts of the DNA solutions were mixed with
suitable volumes of CL liposome dispersions, self-assembled CL/DNA
lipoplexes at desired cationic lipid/DNA charge ratio, ρ, were obtained.
For size and zeta-potential experiments, calf thymus DNA was
used. For confocal ﬂuorescence microscopy experiments, Cy3-labeled
2.7 kbp plasmid DNA (Mirus Bio Corporation, Madison, WI, USA) was
used.
2.3. Lipid–protamine/DNA nanoparticles
Protamine sulfate salt (P) from salmon (MW = 5.1 kDa) was
purchased from Sigma-Aldrich (St. Louis, MO, USA). Positively charged
P/DNA microspheres at RW = 0.5 were mixed with SUVs at the desired
charge ratio, ρ.
2.4. Size and zeta-potential measurements
Size and zeta-potential distributions of CLs, LPD nanoparticles,
and lipoplexes were measured at 25 °C by a Malvern NanoZetaSizer
spectrometer equipped with a 5 mW HeNe laser (wavelength
λ = 632.8 nm) and a digital logarithmic correlator. The normalized in-
tensity autocorrelation functions were analyzed by using the CONTIN
method, which analyzes the autocorrelation function through an in-
verse Laplace transform [28] in order to obtain the distribution of the
diffusion coefﬁcient D of the particles. This coefﬁcient is converted
into an effective hydrodynamic radius RH by using the Stokes–Einstein
equation RH = KBT/(6πηD), where KBT is the thermal energy and η the
solvent viscosity. The electrophoretic mobility measurements werecarried out by means of the laser Doppler electrophoresis technique,
by the same apparatus used for size measurements. The mobility u
was converted into the zeta-potential using the Smoluchowski relation
zeta-potential = uη/ε, where η and ε are the viscosity and the permit-
tivity of the solvent phase, respectively.
2.5. Transfection efﬁciency experiments
Cell lines were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM)withGlutamax-1 (Invitrogen, Carlsbad, CA, USA) supplemented
with 1% penicillin–streptomycin (Invitrogen) and 10% fetal bovine
serum (Invitrogen) at 37 °C and 5% CO2 atmosphere, splitting the cells
every 2–4 days to maintain monolayer coverage. For luminescence
analysis, Chinese hamster ovary (CHO) cells were transfected with
pGL3 control plasmid (Promega, Fitchburg, WI, USA). The day before
transfection, cells were seeded in 24-well plates (150,000 cells per
well) using medium without antibiotics. Cells were incubated until
they were 75–80% conﬂuent, which generally took 18–24 h. For TE
experiments, LPD nanoparticles and lipoplexes were prepared in
Optimem (Invitrogen) by mixing for each well of 24-well plates 10 μl
of sonicated lipid dispersions (1 mg/ml) with 0.5 μg of plasmid
(lipoplexes) or 0.5 μg of plasmid pre-complexed with 0.25 μg of prot-
amine. Complexes were left for 20 min at room temperature before
adding them to the cells. On the day of transfection, the growthmedium
was replaced with 400 μl of Optimem and the cells were incubated for
30 min at 37 °C, before adding 100 μl of lipoplexes or LPD nanoparticles
in Optimem. Cells were incubated at 37 °C for an additional 4 h to per-
mit transient transfection. Finally, to avoid internalization of complexes
that could remain bound to the cell surface after medium replacement,
the cells were extensively washed 3× with phosphate buffered saline
(PBS) before DMEM medium supplemented with 10% fetal bovine
serum at 37 °Cwas added. After 48 h, cells were analyzed for luciferase
expression using Luciferase Assay System from Promega. Brieﬂy, cells
were washed in PBS and harvested in 200 μl 1× reporter lysis buffer
(Promega). Of the cell suspension, 20 μl was diluted in 100 μl luciferase
reaction buffer (Promega) and the luminescence was measured 10 s
using a Berthold AutoLumat luminometer LB-953 (Berthold, Bad
Wildbad, Germany). Results were expressed as relative light units per
mg of cell proteins as determined by Bio-Rad Protein AssayDye Reagent
(Bio-Rad, Hercules, CA). Each condition was performed in quadruple
and repeated three times.
2.6. Flow cytometric analysis
CHO cells were seeded in 24-well plates (450,000 cells/well) using
medium without antibiotics. After 24 h, cells were incubated for 3 h
with LPD NPs or lipoplexes prepared with Cy3-labeled DNA. Cells
were then dissociated and suspended in PBS (1 × 106 cells/sample).
Fluorescence was analyzed by FACScalibur with CellQuest and FLowJo
software (Becton Dickinson, Mountain View, CA, USA).
2.7. Cell culture, transfection, colocalization assay
CHO-K1 cells were purchased from American Type Culture Collec-
tion (CCL-61 ATCC) and were grown in Ham's F12K medium supple-
mented with 10% of fetal bovine serum at 37 °C and in 5% CO2. For
transfection experiments, lipoplexes were prepared in PBS by mixing
1 μl of Cy3-labeled DNA with 10 μl of sonicated lipid dispersions.
These complexes were left for 20 min at room temperature before
adding them to the cells. In order to identify the endocytic vesicles in-
volved in lipoplex internalization, we performed colocalization assays
in living cells. CHO-K1 cells were coincubated with lipoplexes and
different endocytic ﬂuorescent markers: 1 mg/ml 70 kDa dextran–
ﬂuorescein isothiocyanate (FITC) conjugate at 37 °C for 30 min to
label macropinosomes, 50 mM Lysosensor for 30 min to label lyso-
somes, 2 μg/ml transferrin-Alexa488 conjugate for 30 min to label
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carried out using lipofectamine reagent (Invitrogen) according to the
manufacturer's instruction. Colocalization of green and red signals
was analyzed by the ImageJ software (NIH Image; http://rsbweb.nih.
gov/ij/) [29].
To provide quantitative validation of endosomal escape, doubly
labeled complexes were prepared with Cy3-labeled DNA (red) and
NBD-labeled lipids (green). Cells were treated with complexes as for
transfection, and the localization of the complexes monitored by time-
lapse imaging. An estimate of the escape efﬁciency can be given by the
fraction of cytoplasmic DNA, F(cyt), calculated as the pixel area corre-
sponding to the red signal divided by the total pixel area of red and
yellow signals.
2.8. Laser scanning confocal microscopy
Laser scanning confocal microscopy (LSCM) experiments were
performed with the Olympus Fluoview 1000 (Olympus, Melville, NY)
confocal microscope interfaced with a 405 nm diode laser, a 488 nm
Argon laser, and 543 nm helium–neon laser. Glass bottom Petri dishes
containing transfected cells were mounted in a temperature-controlled
chamber at 37 °C and 5% CO2 and viewedwith a 60 × 1.25 numerical ap-
erture (NA) water immersion objective. The following collection ranges
were adopted: 500–540 nm (EGFP, Alexa488-transferrin and FITC–
dextran 70 kDa), 555–655 nm (Cy3), and 460–530 (Lysosensor). Images
were collected in sequential mode to eliminate emission cross talk
between the various dyes.
2.9. Spatio-temporal image correlation spectroscopy
Confocal microscopy experiments were carried out using a Fluoview
FV-1000 (Olympus, Tokyo, Japan) microscope, with the HeNe laser at
543 nm to excite the ﬂuorescently labeled pDNA. Following the practi-
cal guidelines byKolin andWiseman [30], the experimentswere carried
out at 37 °C and were controlled by a data acquisition software (FV10-
ASW, Olympus, Tokyo, Japan). For each region of interest (ROI), a tem-
poral stack of at least 50 raster scanned images of 256 × 256 pixels
was acquired. The pixel size was set equal to 0.1–0.25 μm/pixel, while
the pixel dwell time was set equal to 8–20 μs/pixel. Due to the slow
dynamics of the complexes, the time resolution (i.e. the distance in
timebetween two subsequent frames)was set equal to the frame acqui-
sition time plus a delay time on the order of 1–5 s (Δt in the following).
Data were analyzed by a custom-made data acquisition software
(SimFCS, Laboratory for Fluorescence Dynamics, Irvine, CA, USA —
downloadable from www.lfd.uci.edu) and an additional custom-made
Matlab (The MathWorks, Natick, MA) program. STICS is a powerful
tool that allows us to obtain dynamic parameters of particles within
different ROIs in a confocal two-dimensional image. From the raw tem-
poral stack, a generalized discrete spatio-temporal correlation function
can be deﬁned [31]:
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where δi(x, y, t) = i(x, y, t) − bi(x, y, t)Nt is the intensity ﬂuctuation at
image pixel position (x, y) and time t, the angular brackets in the de-
nominator represent spatial ensemble averaging over images at time
kΔt and kΔt + τ in the time series, X and Y are the number of pixels
spanning the region being analyzed (e.g. X = Y = 16, 32, 64, 128,
256,… pixels), N is the number of images in the image series
(e.g. N = 50 in our experimental data), k is a dummy variable, Δt is
the time resolution and δx = δy is the pixel size. In order to minimize
the contribution of immobile ﬂuorescent cell structures, an immobile
ﬁltering is applied to the image intensities prior to use Eq. (1) [30]. At
zero-lag time (τ = 0), the autocorrelation function g(ξ,η,0) could beﬁtted to a 2D Gaussian centered in (ξ,η) = (0,0). If ﬂow is present, the
peak position moves in the ξ–η plane as a function of τ (ξ(τ) = −vxτ
and η(τ) = −vyτ). Therefore, it is possible to obtain the velocity in
the x–y plane from a linear ﬁtting of the peak position. This ﬁrst step
allows us to distinguish types of motion, i.e. normal diffusion from
ﬂow and diffusion, without any a priori knowledge or assumption. In
order to obtain the diffusion coefﬁcient D, the temporal correlation
function g(0,0,τ) could be ﬁtted to the analytical model equation for
normal diffusion (Eq. (2)) or ﬂow and diffusion (Eq. (3)), according to
the motion categorization achieved in the previous step.
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where g(0,0,0) is the zero-lag amplitude, g∞ is the longtime offset,
bω02N/ωz2is the ratio between the average radial and axial beam
radii, and the characteristic diffusion time τd = bω02N/4D.
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where |v| is the two-dimensional velocity, that in principle should be
equal to the one obtained by tracking the moving peak of the STICS
correlation function.
3. Results
3.1. Size and zeta-potential
DOTAP–DOPC and DC-Chol–DOPE CLs were found to be positively
charged (zeta-potential = 50.3 ± 1.6 and 60.0 ± 2.5 mV, respective-
ly) with a hydrodynamic diameter of D = 110 ± 8 and 98 ± 6 nm,
respectively. To identify themost appropriate cationic lipid/DNA charge
ratio (ρ) for transfection, size and zeta-potential of both lipoplexes and
LPD NPs were measured. In Fig. 1A the hydrodynamic diameter (D) and
the zeta-potential of DOTAP–DOPC/DNA lipoplexes are plotted against
ρ. For 0.5 b ρ b 4, complexes are negatively charged and both their
size and zeta-potential increase with increasing ρ. At ρ ~ 5 DOTAP–
DOPC/DNA lipoplexes become neutrally charged (zeta-potential
~ 0 mV) and exhibit the maximum size (D ~ 2 μm). Further increase
of the lipid content (ρ N 5) induces, as expected, charge inversion and
re-entrant condensation of complexes [32,33]. In the case of DC-Chol–
DOPE/DNA lipoplexes, the same phenomenology was observed, as
reported in Fig. 1B. In more detail, charge inversion and re-entrant
condensation of DC-Chol–DOPE/DNA lipoplexes start at ρ ~ 2.5. In
Fig. 1C, D size and zeta-potential of DOTAP–DOPC/P-DNA and DC-
Chol–DOPE/P-DNANPs are reported. It is worth noting that both charge
and size saturation were found to occur at ρ values much smaller than
those observed for lipoplexes. This ﬁnding indicates that LPD NPs are
deﬁnitely more efﬁcient than lipoplexes in encapsulating DNA. To com-
pare the biological activity of different formulations, the same cationic
lipid/DNA ratio must be chosen. To accomplish this requirement, the
charge ratio ρ = 5 was chosen.
3.2. Transfection efﬁciency
The transfection efﬁciency of lipoplexes prepared in a serum-free
cell culture medium was tested in vitro using the luciferase expression
assay in CHO cells, as described in the Materials and methods
section. Fig. 2 shows that DC-Chol–DOPE/DNA lipoplexes and DC-
Chol–DOPE/P-DNA NPs are about three orders of magnitude more
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Fig. 2. Transfection efﬁciency (TE) in RLUpermg of cellular proteins of lipoplexes and lipid
nanoparticles.
961D. Pozzi et al. / Biochimica et Biophysica Acta 1838 (2014) 957–967efﬁcient than their DOTAP–DOPC counterpart. At the same time, TE of
DC-Chol–DOPE/P-DNA NPs is about 2-fold times higher than that of
DC-Chol–DOPE/DNA lipoplexes. This quantitative picture of the overall
transfection process conﬁrms the potential superior efﬁcacy of LPD
NPs as compared with lipoplexes. To understand which intracellular
barriers and/or processes are responsible for the different transgene ex-
pressions, we performed a quantitative mechanism-based investigation
comparing the cell uptake, intracellular trafﬁcking, endosomal escape
and ﬁnal fate of the four formulations in the selected cell line.
3.3. Cell uptake
In Fig. 3 we report the amount of ﬂuorescent positive cells after 3 h
of incubation with lipoplexes and LPD NPs at 37 °C, measured by ﬂow
cytometry. These data support two main conclusions: i) cellular uptake
of lipoplexes is higher than that of their LPDNP counterparts; ii) for both
lipoplexes and LPDNPs cellular uptake of theDOTAP–DOPC-based com-
plexes is higher than that of the DC-Chol–DOPE-based ones. It is re-
markable that, upon CHO treatment with the less efﬁcient formulation
of DOTAP–DOPC/DNA lipoplexes, cell uptake reached a level as high as
~40%, anyhow superior to the most efﬁcient formulation of DC-Chol–
DOPE/P-DNA NPs (less than 10%). Although in the high-ﬂuorescence
population (less than 3%), the average ﬂuorescence intensity of LPD
NPs was larger than that of lipoplexes (data not reported), we are
prompted to conclude that cellular uptake does not correlate with the
measured transgene expression (Fig. 2).0
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Fig. 3. Cell uptake of lipoplexes and lipid nanoparticles given as percentage of ﬂuorescent
positive cells after 3 h of incubation with at 37 °C.3.4. Uptake mechanism
To deﬁne the endocytotic route of lipid-mediated DNA delivery,
CHO cells were treated with Cy3-DNA (red) and co-labeled with
speciﬁc markers of endocytic pathways (green): clathrin-mediated
endocytosis (Alexa488-labeled transferrin), caveolae-mediated en-
docytosis (caveolin-E1GFP) and macropinocytosis (70 kDa dextran).
Colocalization of red and green ﬂuorescence gave rise to visible
yellow/orange punctate structures (Fig. 4). In addition to a qualitative
inspection of confocal images, we performed a quantitative analysis of
the ﬂuorescence signal biodistribution by applying an object-based
colocalization analysis protocol previously described [34]. The
colocalization values are given as the fraction of cell-associated NPs
colocalizing with ﬂuorescently labeled endocytotic structures. At
N = 20 cells, the colocalization parameters reached a plateau (not
reported), suggesting that such a number of measurement repetitions
was enough for a general conclusion to be valid. Therefore, in the
following, each analyzed group is composed of at least 20 cells. At 1 h
of treatment, DOTAP–DOPC/DNA and DC-Chol–DOPE/DNA lipoplexes
do not colocalize with caveolin-E1GFP (Fig. 4A, B). This result clearly
indicates that lipoplexes do not use this pathway to enter CHO cells.
Similar conclusions can be drawn at t = 30 min for clathrin dependent
endocytosis, in view of the lack of co-localization of the Cy3-DNA with
Alexa488-labeled transferrin. Lastly, we used a ﬂuorescently labeled
70 kDa dextran to visualize ﬂuid phase macropinocytosis. Since
macropinocytosis is slower than other endocytosis pathways, measure-
ments were performed after 3 h of incubation. At this time point we
observe that both lipoplex formulations considerably colocalize with
the dextran marker, indicating macropinocytosis as the preferential
pathwayof lipoplex entry into CHO cells. By contrast, the internalization
of LPD NPs is more heterogeneous in nature, as an increased number of
NPs at any time would be able to occupy labeled endocytic vesicles
(Fig. 4C, D), compared to the case with lipoplexes. Similarly to what is
observed for lipoplexes, a fraction of NPs shows colocalization with
macropinosomes. By contrast, however, image analysis reveals a positive
contribution of clathrin-mediated endocytosis, as demonstrated by the
signiﬁcant overlap of the ﬂuorescence signals from Cy3-DNA and
Alexa488-labeled transferrin. It is worth noting that by summing the
fractional contributions of all the mechanism involved in NP uptake,
we obtain a number above 1. This is not surprising, in light of the well
known structural overlapping between the different intracellular endo-
cytotic pathways (e.g. the same endosome can be populated by mole-
cules taken up by macropinocytosis or clathrin-mediated endocytosis).
In summary, LSCM shows that, while lipoplexes enter CHO cells
exclusively through ﬂuid-phase macropinocytosis, LPD NPs can
use two different endocytosis pathways: macropynocitosis and
clathrin-mediated endocytosis.
3.5. Intracellular trafﬁcking
To date, most of the studies have focused on identifying the way of
entry and ﬁnal destination of nanocarriers [35], while completely miss-
ing their intracellular trafﬁcking and interactions. To address this chal-
lenge, some of us recently introduced a quantitative method based on
STICS that allows for characterizing themode of motion of nanocarriers
and for quantifying their transport parameters as they move through
the cytosol in a living cell [36]. Fig. 5 introduces the fundamental steps
of this analysis for a representative time series of DC-Chol–DOPE-P/
DNA NPs. Fig. 5A is the superimposition of DC-Chol–DOPE-P/DNA NP
ﬂuorescence and the Nomarski image of the corresponding cell. By
Eq. (1) we calculate the STICS function and ﬁt it to a 2D Gaussian. The
ROI size is ﬁrst set to the image size, i.e. 256 × 256 pixels; this allows
us to extract the average information about the intracellular dynamics
motion of lipoplexes and LPD nanoparticles at the single-cell level.
Without any previous assumption, it is possible to follow the 2D Gauss-
ian peak motion from Fig. 5B in the x–y plane. From a linear
caveolae-mediated
endocytosis
clathrin-mediated
endocytosis
macropinocytosis
0
0.2
0.4
0.6
0.8
1
1.2
Caveolae Clathrin Macropinocytosis
0
0.2
0.4
0.6
0.8
1
1.2
0
0.2
0.4
0.6
0.8
1
1.2
0
0.2
0.4
0.6
0.8
1
1.2
A
B
C
D
Fig. 4.Colocalization of DOTAP–DOPC/DNA (panel A), DC-Chol–DOPE/DNA (panel B) lipoplexes andDOTAP–DOPC/P-DNA (panel C), DC-Chol–DOPE/P-DNA (panel D) nanoparticle signals
(red) with speciﬁc markers of endocytic pathways (green): clathrin-mediated endocytosis (Alexa488-labeled transferrin), caveolae mediated endocytosis (caveolin-E1GFP) and
macropinocytosis (70 kDa dextran). The histograms on the left show an object-based colocalization analysis protocol. The colocalization values are given as the fraction of cell-
associated nanoparticles colocalizing with ﬂuorescently labeled endocytic structures.
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the velocity can be retrieved as well as the particle velocity, vSTICS
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v2x þ v2y
q
. According to Herbert et al. [31], when vSTICS b 0.009 μm/
s, the motion can be categorized as Brownian diffusion, while a value
of vSTICS N 0.009 μm/s is clear indication of an active mode of motion.
After having categorized the motion as combination of ﬂow and diffu-
sion, one can obtain the diffusion coefﬁcient, DTICS, and the velocity,
vTICS, by ﬁtting g(0,0,τ), to Eq. (3). By its nature, the STICS technique
measures an ensemble of particles and can report average values but
not their distribution, as can be done by using single particle tracking
(SPT). However, due to the ability of correlation techniques to analyze
distinct ROIs in a confocal image, we could investigate the motion of
particles within different subcellular regions. By segmenting the
single-cell images into boxes as small as 64 × 64 pixels we revealed
the presence of distinct local dynamics. In more detail, we observe
that a large fraction of both lipoplexes and LPD nanoparticles is actively
transported, while, in some less frequent cases, they mainly display a
diffusivemotion. Table 1 lists the average dynamic parameters obtainedby applying this analysis to all temporal stacks acquired for lipoplexes
and LPD nanoparticles. With respect to the mode of motion neither
the kind of the delivery system nor the lipid formulation affords a rea-
sonable explanation for the observed differences in TE.
3.6. Endosomal escape
As endosomes maturate and fuse (and travel to the perinuclear re-
gion, the location of the lysosomal compartment), several particles
may share the same endosomal compartment and become indistin-
guishable by LSCM as their separation is smaller than the resolution
limit of the microscope. This effect should be more pronounced for
particles that remain trapped in endosomes, which indeed look like
larger, brighter spots in the images. As Fig. 6 shows, this is clearly the
case of DOTAP–DOPC-based nanocarriers. Conversely, DC-Chol–DOPE-
based complexes that appear as small, point-like particles remain spa-
tially separated and are possibly more prone to escape from endosomal
compartments. To provide quantitative validation of this suggestion,
Fig. 5. Steps of the STICS analysis: (A) superimposition of the confocal ﬂuorescence image (theﬁrst image of the temporal stack) on top of the corresponding CHO-K1 cell Nomarski image;
(B) the STICS functions at τ = Δt and 7Δt (the vertical black line helps to follow themotion of the STICS peak position); (C) the x- and y-coordinates (ﬁlled diamonds and squares, respec-
tively) of the 2DGaussian peakposition as a function of the delay time τ. The solid line is the best linearﬁt to thedata. From the slope of the linearﬁts, the velocities (vSTICS) along the x- and
y-directions could be calculated; (D) the raw temporal image correlation function (circles) and the relatedﬁt (solid line) using Eqs. (2) and (3) (depending on the type ofmotion) to obtain
the dynamic parameters, i.e. the velocity vTICS and the diffusion coefﬁcient DTICS.
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and NBD-labeled lipids (green in Fig. 6). Cells were treated with
complexes as for transfection, and the localization of the complexes
monitored by time-lapse imaging. After 4 h, cells show a punctuate
ﬂuorescence pattern: yellow clusters, as indicated by yellow arrows,
are proof of the colocalization of the pDNA (red) and shell lipids
(green), i.e. proof of the complex integrity. Isolated red clusters (red
arrows) can be reasonably deﬁned as cytoplasmic DNA. According to
literature [37], each red cluster consists of a several DNA molecules,
not a single one, and the pixel areas reﬂect the amount of the DNA in
each cluster. Large (N1 μm) patches of red ﬂuorescence appear indicat-
ing that DC-Chol–DOPE-based complexes largely escaped the endo-
some pathway. In this reasoning, an estimate of the escape efﬁciency
can be given by the fraction of cytoplasmic DNA, F(cyt), calculated as
the pixel area corresponding to the red signal divided by the total
pixel area of red and yellow signals [37]. After transfection with DC-
Chol–DOPE/DNA for 3 h, we selected up to 50 clusters randomly (in
not less than 20 cells) to calculate the fraction of DNA in the cytoplasm.Table 1
Average dynamical parameters of lipoplexes and LPD NPs as obtained by the peak move-
ment of the STICS function (vSTICS) and by ﬁtting the temporal image correlation function
using Eqs. (2) and (3) (vTICS and DTICS).
vSTICS [μm/s] vTICS [μm/s] DTICS [μm2/s]
DOTAP–DOPC/DNA 0.0104 ± 0.0088 0.0225 ± 0.0106 0.0010 ± 0.0008
DOTAP–DOPC-P/DNA 0.0178 ± 0.0145 0.0219 ± 0.0123 0.0013 ± 0.0012
DC-Chol–DOPE/DNA 0.0298 ± 0.0149 0.0216 ± 0.0069 0.0010 ± 0.0007
DC-Chol–DOPE/P-DNA 0.0190 ± 0.0150 0.0192 ± 0.0115 0.0015 ± 0.0013As Fig. 6E shows, values of F(cyt) were in the following order: DOTAP–
DOPC/DNA b DOTAP–DOPC-P/DNA b DC-Chol–DOPE/DNA b DC-Chol–
DOPE-P/DNA. Our results suggest that escape from lipid vesicles is
responsible for the levels of transgene expression in TE experiments.
3.7. Lysosomal degradation
In previous section we have demonstrated that endosomal escape
efﬁciency does correlate with TE. It cannot be excluded, however,
that the fraction of DNA entrapped in vesicles 4 h after transfection
(1-F(cyt)) might escape from endosomes on longer timescales. As a
consequence, this fraction may be further divided into two sub-
fractions: the fraction of DNA complexed with cationic lipid vesicles
that is contained in the lysosome compartment (F(lys)) (destined to
degradation) and the fraction of DNA that stays in vesicles that are not
transported to lysosomes (F(lip)). Initially, we labeled the CHO cells
with Lysosensor, a well-known lysosomemarker (Fig. 7). Consequently,
the cy3-DNA signal colocalizedwith the green Lysosensor signal (yellow
clusters) was interpreted as the fraction of DNA in lysosomes, F(lys).
After 3 h of incubation with DOTAP–DOPC/DNA lipoplexes, a marked
colocalization of red and green ﬂuorescence in large perinuclear vesicu-
lar structures was observed (Fig. 7A). This observation suggests that
DOTAP–DOPC/DNA lipoplexes are largely destined to metabolic degra-
dation in the lysosomes and provides a reasonable explanation for
their low TE (Fig. 2). Strikingly, when CHO cells are transfected with
DC-Chol–DOPE/DNA lipoplexes, a substantially lower degree of
colocalization of Cy3-DNA and Lysosensor is detected (Fig. 7B). Fig. 7C,
D also shows that labeled LPD NPs exhibit a further lower colocalization
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Fig. 6. Laser scanning confocal microscopy on live CHO cells using doubly labeled complexes prepared with Cy3-labeled DNA (red) and NBD-labeled lipids (green): (panel A) DOTAP–
DOPC/DNA lipoplexes, (panel B) DC-Chol–DOPE/DNA lipoplexes, (panel C) DOTAP–DOPC/P-DNA nanoparticles, (panel D) DC-Chol–DOPE/P-DNA nanoparticles. Yellow clusters, as indi-
cated by yellow arrows, represent the colocalization of thepDNA (red) and lipids (green). Other red clusters not colocalizedwith green structure (as indicated by red arrows)were deﬁned
as cytoplasmic pDNA. The histogram on the left shows the fraction of cytoplasmic DNA, F(cyt), calculated as the pixel area of the red signal divided by the total pixel area of the red and
yellow signals [37].
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object-based colocalization analysis protocol described above, we quan-
titatively addressed the fraction of DNA complexed with cationic lipid
vesicles that is contained in lysosomes. This analysis (Fig. 7E) shows
that the degree of colocalization of nanocarriers with Lysosensor was
in the order: DOTAP–DOPC/P-DNA N DOTAP–DOPC/DNA N DC-Chol–
DOPE/DNA N DC-Chol–DOPE/P-DNA. This further clariﬁes why DC-
Chol–DOPE-mediated DNA delivery could provide a much greater
transfection efﬁciency than that of DOTAP–DOPC/DNA complexes.
Discussion
The successful design of a nonviral gene nanocarriers requires a deep
understanding of themechanisms involved in their interactionwith the
target cells. However, in the majority of the studies, the ﬁnal transfec-
tion efﬁciency has been used as the only parameter to deﬁne their
success. Consequently, it is difﬁcult to predict which of the intracellular
barriers represent the main rate-limiting factor in the transfection
process. At each intracellular barrier, the nanocarrier has a certain
chance of success (i.e. overcome the barrier and go forward in the pro-
cess). The cumulative probability of success for the entire journey is
revealed by the speciﬁc TE of the given system. In the present study,B
D
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C
D
F(
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) 
Fig. 7.Colocalization of DOTAP–DOPC/DNA (panel A), DC-Chol–DOPE/DNA (panel B) lipoplexes
(red) with Lysosensor (lysosome marker, green). (panel E) Fraction of DNA in the lysosomes, Fwe compare the intracellular distribution of exogenousDNA transfected
by multilamellar lipoplexes and core–shell type LPD NPs in CHO living
cells. We were aimed at increasing our overall understanding of the
sequence of events in lipid-mediated DNA delivery. Thus, we propose
a combined experimental approach that is able to quantitatively and
separately address each step of transfection process. At ﬁrst, we investi-
gated the formation of complexes by simultaneous determination
of size and zeta-potential. As expected, both lipoplexes and LPD NPs
exhibited charge inversion and re-entrant condensation, although
with a pronounced higher DNA compaction ability by NPs as compared
to lipoplexes. Overall, this characterization allowed us to determine the
optimum cationic lipid/DNA charge ratio for TE experiments. Regarding
the latter, we detected that DC-Chol–DOPE/DNA lipoplexes and DC-
Chol–DOPE/P-DNA NPs were about three orders of magnitude more
efﬁcient than their DOTAP–DOPC-based counterparts. Among them,
DC-Chol–DOPE/P-DNA NPs showed 3-fold higher luciferase expression
than DC-Chol–DOPE/DNA lipoplexes. To account for those differences
in TE, we ﬁrst quantiﬁed the cellular uptake of lipoplexes and LPD NPs
in terms of percentage of positive (ﬂuorescent) cells by ﬂow cytometry.
Surprisingly, internalization efﬁciencies showed a clear anti-correlation
with respect to the corresponding TE: e.g. DC-Chol–DOPE/P-DNA NPs
yielded the highest TE but the lowest cellular uptake. This outcome0
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andDOTAP–DOPC/P-DNA (panel C), DC-Chol–DOPE/P-DNA (panel D) nanoparticle signals
(lys), calculated by using an object-based colocalization protocol.
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tions may proceed along different routes. It has been well recognized
that lipid/DNA complexes are mainly taken up through endocytosis,
but different pathways, with distinct intracellular destinies, have been
alternatively proposed [20,21,38]. As a result, a promising strategy for
increasing the efﬁciency of non-viral vectors is to target certain uptake
pathways that improve the intracellular fate of the particles. Such a
plan requires a comprehensive understanding of the different uptake
pathways and the subsequent intracellular events in each case. By
confocal imaging and colocalization assays, here we deﬁne that the
cell entry of lipoplexes occurs through macropinocytosis, while that of
LPD NPs equally through macropinocytosis and the classical clathrin-
associated endocytosis. To explain this phenomenon, a size-dependent
differential uptake of the particles could be considered [20]. It appears,
in fact, that the size of lipoplexes (generally more than 200 nm) is
too large to be taken up via nonacidic vesicular transport such as
caveolin-mediated endocytosis (diameter of caveolae ~60–90 nm)
and clathrin-dependent endocytosis (diameter of clathrin-coated
vesicles ~100–120 nm), while some LPD NPs are small enough to be
internalized via clathrin-dependent endocytosis. Irrespective of the
speciﬁc route taken, once inside the cell complexes need to travel long
distances through the cytoplasm to reach the cell nucleus. Since diffu-
sion through the dense meshwork of the cytoplasm is not likely, other
mechanisms must exist by which nanocarriers can move towards the
cell nucleus. Recently, it became clear that the cytoskeleton does not
constitute a barrier for successful gene delivery, but on the contrary, it
actively contributes to DNA transport, just as it does for viruses
[36,39,40]. Here we addressed the nanocarrier intracellular trafﬁcking
by means of a recently introduced method, based on STICS, which
enables the particle motion to be quantiﬁed in individual cells with
sequential images captured by laser scanning confocal microscopy
[36]. By this approachwe proved that a large fraction of both lipoplexes
and LPD nanoparticles is actively transported, with a minor concomi-
tant contribution of a diffusion-like motion. Our results (Table 1)
are consistent with previous reports showing that gene vectors
are transported with typical velocity varying between ≈0.02 and
≈0.2 μm s−1 depending on several factors such as the lipid species
and the particle size. Results from the four formulations reveal very
similar dynamic behaviors, with the average velocities and diffusion co-
efﬁcients being in the same range of values. Thus, we can conclude that
active transport plays some important role in plasmid trafﬁcking, but it
seems not to be a signiﬁcant barrier against transfection. Since
endosomal escape and lysosomal degradation of plasmid DNA consti-
tute a major barrier for transgene expression, a quantitative evaluation
of these barrierswould behighly desirable in terms of optimizing a non-
viral gene delivery system. Actually, entrapment and degradation can
be regarded as two separate barriers, because preventing lysosomal
degradation results in an accumulation of genes in intracellular vesicles
without enhancing cytosolic release. Therefore, to reach the nucleus,
DNA must avoid degradation within lysosomes but concomitantly
escape from intracellular vesicles into the cytosol. To evaluate the
extent to which this pathway contributes to the cytoplasmic distribu-
tion of DNA, we evaluated the escape efﬁciency through quantiﬁcation
of the fraction of cytoplasmic DNA, F(cyt). 4 h after transfection ﬂuores-
cent particles are seen inside of the cells in a punctuate pattern (Fig. 6).
In the case of the poorly efﬁcient DOTAP–DOPC/DNA lipoplexes
(Fig. 6A), most of the DNA is not released from cationic lipid/vesicles
and consequently detected in the cytosol (F(cyt) b 0.1), suggesting
that poor endosomal escape may be responsible for low transgene
expression. By contrast, DC-Chol–DOPE/DNA lipoplexes (Fig. 6C) and
DC-Chol–DOPE/P-DNA NPs (Fig. 6D) show a signiﬁcantly higher value
of cytoplasmic DNA (F(cyt) ≈ 0.5 and 0.7 respectively), which clearly
indicates that DC-Chol–DOPE-based systems have a superior efﬁcacy
in terms of escape into the cytosol. This remarkable property is most
probably due to the speciﬁc contribution of DOPE, due to its intrinsic
ability to promote lamellar-to-hexagonal phase transitions, resultingin endosomal membrane perturbation and/or disruption. Furthermore,
the use of cholesterol-like molecules, as DC-Chol is, in the lipoplex for-
mulation has been shown to enhance transfection both in vitro and
in vivo. In vitro this could be due, at least in part, to the formation of
cholesterol nanodomains in the lipoplex membrane that may play a
role either in cellular uptake or in intracellular trafﬁcking [12,41–43].
In addition, the role of cationic lipids deserves consideration. Indeed,
DOTAP is a pH-insensitive lipid with a permanent cationic charge,
while DC-Chol has a titrable tertiary amine group (pKa = 7.8). This
means that at physiological pH DC-Chol is partially deprotonated
resulting in reduced surface charge. Reduction of the cationic charge
could weaken the lipid/DNA attraction with the result that DNA could
be more easily released from lipoplexes. Fig. 6D also shows that, for a
given lipid composition, LPD NPs are about 2-fold superior with respect
to their lipoplex counterparts in terms of DNA delivery to the cytosol. A
possible explanation arises from the different nanostructures of these
complexes. It is accepted that, upon nanocarrier–cellularmembrane in-
teraction, anionic cellular lipids laterally diffuse into the complex and
locally neutralize cationic lipids [44]. Formation of cationic/anionic
mixed bilayers is expected to weaken the electrostatic attraction
between cationic lipids and anionic DNA molecules. Only when the
membrane charge density of cationicmembranes is completely neutral-
ized by anionic lipids theDNAdoes start to escape fromcomplexes in an
appreciable manner [45]. While lipoplexes are multilamellar structures
made of some tenths of alternating lipid/DNA layers, LPD NPs are made
of DNA complexed with a polycation and encapsulated by a lipid enve-
lope made of a few layers. The ability of LPD NPs to escape from
endosomes is presumably related to the more favorable interaction
between cationic and anionic cellular lipids due to the absence of com-
peting DNA in the lipid envelope and to the lower number of lipid layers
to be peeled off. Moreover, some authors have recently shown that the
endosomal escape of lipid gene vectors is extremely low [46]. According
to their results, core–shell NPs (containing protamine) may show a
burst release from endosomes, whereas lipoplexes could exhibit a
more gradual release.
According to literature [37]we evaluated the endosomal escape abil-
ity 4 h after transfection. However, DNAmight escape from endosomes
on longer timescales. On the other side, it is believed that DNAentry into
lysosomes is followed by degradation resulting in transfection failure.
Thus, to account for differences in TE, ﬁnal fate of complexes was
compared by the fraction of DNA in the lysosomes, F(lys). When CHO
cells are treated with DOTAP–DOPC/DNA lipoplexes and DOTAP–
DOPC/P-DNA NPs, the majority of DNA-containing vesicles coincides
with the lysosome compartment (F(lys) = 0.58 and 0.70 respectively),
conﬁrming that metabolic degradation is the rate-limiting factor in
DOTAP–DOPC-mediated transfection. On the opposite, the fraction of
DNA in lysosomes is much lower for DC-Chol–DOPE/DNA lipoplexes
and DC-Chol–DOPE/P-DNA NPs (F(lys) = 0.35 and 0.17 respectively).
As a last step towards identifying intracellular barriers responsible for
the difference in TE the post-nuclear delivery processes must be inves-
tigated [47]. Additionally, to bring optimized nanocarriers to the fore-
front of gene delivery, understanding how transfection mechanisms
are affected by the ‘protein corona’ [48–56] displayed by nanocarriers
after exposure to biological ﬂuids is an urgent task.
Conclusions
Collectively, we successfully quantiﬁed the cellular uptake, intracel-
lular trafﬁcking and ﬁnal fate of two formulations of lipoplexes and LPD
NPs. As a result, the differences in transgene expression could be ex-
plained by the differences in intracellular fate, such as the efﬁciency of
endosomal escape of the DNA and its lysosomal degradation. The
lipid-dependent and structure-dependent enhancement of transfection
activity suggests that DNA is delivered to the nucleus synergistically:
the process requires both the membrane-fusogenic activity of the
nanocarrier envelope and lipid specieswith intrinsic endosomal rupture
966 D. Pozzi et al. / Biochimica et Biophysica Acta 1838 (2014) 957–967ability. The acquired knowledge can serve as a guideline for future
studies on the optimization of non-viral gene vectors. The last barrier
to efﬁcient transfection is the nuclear entry. This mechanism of action
is strongly dependent on cell division [57,58] and is currently being
investigated in our laboratory.
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